Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,530.00p
   
  • Change Today:
    -24.00p
  • 52 Week High: 6,070.00p
  • 52 Week Low: 2,234.00p
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 11,529
  • Market Cap: £1,664.07m
  • RiskGrade: 128

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
30-Jun-17 Interim 00.00      
  Final 13.30p 25-Nov-11 09-Nov-11 11-Nov-11
30-Jun-18 Interim 8.10p 04-Apr-18 08-Mar-18 09-Mar-18
  Final 17.90p 30-Nov-18 15-Nov-18 16-Nov-18
30-Jun-19 Interim 8.90p 04-Apr-19 07-Mar-19 08-Mar-19
  Final 18.80p 29-Nov-19 07-Nov-19 08-Nov-19
30-Jun-20 Interim 9.40p 02-Apr-20 05-Mar-20 06-Mar-20
  Final 19.70p 11-Dec-20 19-Nov-20 20-Nov-20
30-Jun-21 Interim 10.30p 01-Apr-21 04-Mar-21 05-Mar-21
  Final 21.70p 10-Dec-21 18-Nov-21 19-Nov-21
30-Jun-22 Interim 10.30p 31-Mar-22 03-Mar-22 04-Mar-22

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,530.00p
Change Today -24.00p
% Change -0.94 %
52 Week High 6,070.00p
52 Week Low 2,234.00p
Volume 11,529
Shares Issued 65.77m
Market Cap £1,664.07m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.7% below the market average94.7% below the market average94.7% below the market average94.7% below the market average94.7% below the market average
92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average
Price Trend
80.16% below the market average80.16% below the market average80.16% below the market average80.16% below the market average80.16% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average
Income
84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
48.05% above the market average48.05% above the market average48.05% above the market average48.05% above the market average48.05% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 04-Jul-2022

Time Volume / Share Price
15:43 37 @ 2,530.00p
15:43 3 @ 2,530.00p
15:39 17 @ 2,538.00p
15:36 18 @ 2,540.00p
15:36 3 @ 2,540.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page